133 related articles for article (PubMed ID: 35658206)
1. FRA-1: A key factor regulating signal transduction of tumor cells and a potential target molecule for tumor therapy.
Zeng F; He J; Jin X; Liao Q; Chen Z; Peng H; Zhou Y
Biomed Pharmacother; 2022 Jun; 150():113037. PubMed ID: 35658206
[TBL] [Abstract][Full Text] [Related]
2. Expression of activator protein-1 (AP-1) family members in breast cancer.
Kharman-Biz A; Gao H; Ghiasvand R; Zhao C; Zendehdel K; Dahlman-Wright K
BMC Cancer; 2013 Sep; 13():441. PubMed ID: 24073962
[TBL] [Abstract][Full Text] [Related]
3. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells.
Vial E; Marshall CJ
J Cell Sci; 2003 Dec; 116(Pt 24):4957-63. PubMed ID: 14625389
[TBL] [Abstract][Full Text] [Related]
4. Fra-1 is upregulated in lung cancer tissues and inhibits the apoptosis of lung cancer cells by the P53 signaling pathway.
Zhong G; Chen X; Fang X; Wang D; Xie M; Chen Q
Oncol Rep; 2016 Jan; 35(1):447-53. PubMed ID: 26549498
[TBL] [Abstract][Full Text] [Related]
5. Fra-1/AP-1 induces EMT in mammary epithelial cells by modulating Zeb1/2 and TGFβ expression.
Bakiri L; Macho-Maschler S; Custic I; Niemiec J; Guío-Carrión A; Hasenfuss SC; Eger A; Müller M; Beug H; Wagner EF
Cell Death Differ; 2015 Feb; 22(2):336-50. PubMed ID: 25301070
[TBL] [Abstract][Full Text] [Related]
6. A 19S proteasomal subunit cooperates with an ERK MAPK-regulated degron to regulate accumulation of Fra-1 in tumour cells.
Pakay JL; Diesch J; Gilan O; Yip YY; Sayan E; Kolch W; Mariadason JM; Hannan RD; Tulchinsky E; Dhillon AS
Oncogene; 2012 Apr; 31(14):1817-24. PubMed ID: 21874050
[TBL] [Abstract][Full Text] [Related]
7. Role of Fra-2 in cancer.
Rampioni Vinciguerra GL; Capece M; Scafetta G; Rentsch S; Vecchione A; Lovat F; Croce CM
Cell Death Differ; 2024 Feb; 31(2):136-149. PubMed ID: 38104183
[TBL] [Abstract][Full Text] [Related]
8. Fra-1 a target for cancer prevention or intervention.
Young MR; Colburn NH
Gene; 2006 Sep; 379():1-11. PubMed ID: 16784822
[TBL] [Abstract][Full Text] [Related]
9. Fra-1 is a key driver of colon cancer metastasis and a Fra-1 classifier predicts disease-free survival.
Iskit S; Schlicker A; Wessels L; Peeper DS
Oncotarget; 2015 Dec; 6(41):43146-61. PubMed ID: 26646695
[TBL] [Abstract][Full Text] [Related]
10. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells.
Belguise K; Kersual N; Galtier F; Chalbos D
Oncogene; 2005 Feb; 24(8):1434-44. PubMed ID: 15608675
[TBL] [Abstract][Full Text] [Related]
11. PKCθ-induced phosphorylations control the ability of Fra-1 to stimulate gene expression and cancer cell migration.
Belguise K; Cherradi S; Sarr A; Boissière F; Boulle N; Simony-Lafontaine J; Choesmel-Cadamuro V; Wang X; Chalbos D
Cancer Lett; 2017 Jan; 385():97-107. PubMed ID: 27816489
[TBL] [Abstract][Full Text] [Related]
12. FRA-1 expression level modulates regulation of activator protein-1 activity by estradiol in breast cancer cells.
Philips A; Teyssier C; Galtier F; Rivier-Covas C; Rey JM; Rochefort H; Chalbos D
Mol Endocrinol; 1998 Jul; 12(7):973-85. PubMed ID: 9658402
[TBL] [Abstract][Full Text] [Related]
13. Fra-1 substitutes for c-Fos in AP-1-mediated signal transduction in retinal apoptosis.
Wenzel A; Iseli HP; Fleischmann A; Hafezi F; Grimm C; Wagner EF; Remé CE
J Neurochem; 2002 Mar; 80(6):1089-94. PubMed ID: 11953459
[TBL] [Abstract][Full Text] [Related]
14. The role of the AP-1 transcription factors c-Fos, FosB, Fra-1 and Fra-2 in the invasion process of mammary carcinomas.
Milde-Langosch K; Röder H; Andritzky B; Aslan B; Hemminger G; Brinkmann A; Bamberger CM; Löning T; Bamberger AM
Breast Cancer Res Treat; 2004 Jul; 86(2):139-52. PubMed ID: 15319566
[TBL] [Abstract][Full Text] [Related]
15. Old players with a newly defined function: Fra-1 and c-Fos support growth of human malignant breast tumors by activating membrane biogenesis at the cytoplasm.
Motrich RD; Castro GM; Caputto BL
PLoS One; 2013; 8(1):e53211. PubMed ID: 23301044
[TBL] [Abstract][Full Text] [Related]
16. Integrin-uPAR signaling leads to FRA-1 phosphorylation and enhanced breast cancer invasion.
Annis MG; Ouellet V; Rennhack JP; L'Esperance S; Rancourt C; Mes-Masson AM; Andrechek ER; Siegel PM
Breast Cancer Res; 2018 Jan; 20(1):9. PubMed ID: 29382358
[TBL] [Abstract][Full Text] [Related]
17. Effect of estrogen and tamoxifen on the expression pattern of AP-1 factors in MCF-7 cells: role of c-Jun, c-Fos, and Fra-1 in cell cycle regulation.
Babu RL; Naveen Kumar M; Patil RH; Devaraju KS; Ramesh GT; Sharma SC
Mol Cell Biochem; 2013 Aug; 380(1-2):143-51. PubMed ID: 23625206
[TBL] [Abstract][Full Text] [Related]
18. Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently.
Young MR; Nair R; Bucheimer N; Tulsian P; Brown N; Chapp C; Hsu TC; Colburn NH
Mol Cell Biol; 2002 Jan; 22(2):587-98. PubMed ID: 11756554
[TBL] [Abstract][Full Text] [Related]
19. Fra-1 is downregulated in cervical cancer tissues and promotes cervical cancer cell apoptosis by p53 signaling pathway in vitro.
Xiao S; Zhou Y; Yi W; Luo G; Jiang B; Tian Q; Li Y; Xue M
Int J Oncol; 2015 Apr; 46(4):1677-84. PubMed ID: 25651840
[TBL] [Abstract][Full Text] [Related]
20. Fos-related antigen 1 modulates malignant features of glioma cells.
Debinski W; Gibo DM
Mol Cancer Res; 2005 Apr; 3(4):237-49. PubMed ID: 15831677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
